HATFIELD, England, April 22, 2015 / PRNewswire — Halaven(R) (eribulin) launches today in the United Arab Emirates (UAE) for the treatment of women with locally advanced or metastatic breast cancer (MBC). Eribulin is a life extending treatment for women with …
Eisai Europe Limited
Life-extending Advanced Breast Cancer Treatment Halaven(R) (Eribulin Mesylate) Launched in Kingdom of Saudi Arabia
HATFIELD, England, February 26, 2015 / PRNewswire –
– For EMEA media only: not for Swiss/U.S. Journalists
Innovative breast cancer treatment Halaven(R) (eribulin mesylate) has recently been approved by the Saudi Food and Drug Authority (SFDA) for the treatment of …